Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load.
Lévy Y, Thiébaut R, Montes M, Lacabaratz C, Sloan L, King B, Pérusat S, Harrod C, Cobb A, Roberts LK, Surenaud M, Boucherie C, Zurawski S, Delaugerre C, Richert L, Chêne G, Banchereau J, Palucka K.
Lévy Y, et al. Among authors: palucka k.
Eur J Immunol. 2014 Sep;44(9):2802-10. doi: 10.1002/eji.201344433.
Eur J Immunol. 2014.
PMID: 25042008
Free article.
Clinical Trial.